Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

1.

Aptamers and Their Potential to Selectively Target Aspects of EGF, Wnt/β-Catenin and TGFβ-Smad Family Signaling.

Conidi A, van den Berghe V, Huylebroeck D.

Int J Mol Sci. 2013 Mar 26;14(4):6690-719. doi: 10.3390/ijms14046690.

PMID:
23531534
[PubMed]
Free PMC Article
2.

Cross-talk between the TGFbeta and Wnt signaling pathways in murine embryonic maxillary mesenchymal cells.

Warner DR, Greene RM, Pisano MM.

FEBS Lett. 2005 Jul 4;579(17):3539-46.

PMID:
15955531
[PubMed - indexed for MEDLINE]
Free Article
3.
4.

Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.

Mori Y, Ishida W, Bhattacharyya S, Li Y, Platanias LC, Varga J.

Arthritis Rheum. 2004 Dec;50(12):4008-21.

PMID:
15593186
[PubMed - indexed for MEDLINE]
Free Article
5.

The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.

Lei S, Dubeykovskiy A, Chakladar A, Wojtukiewicz L, Wang TC.

J Biol Chem. 2004 Oct 8;279(41):42492-502. Epub 2004 Jul 28.

PMID:
15292219
[PubMed - indexed for MEDLINE]
Free Article
6.

Divergence of epidermal growth factor - transforming growth factor beta signaling in embryonic orofacial tissue.

Bhattacherjee V, Greene RM, Michele Pisano M.

In Vitro Cell Dev Biol Anim. 2003 May-Jun;39(5-6):257-61.

PMID:
12880367
[PubMed - indexed for MEDLINE]
7.

Sequence-specific peptide aptamers, interacting with the intracellular domain of the epidermal growth factor receptor, interfere with Stat3 activation and inhibit the growth of tumor cells.

Buerger C, Nagel-Wolfrum K, Kunz C, Wittig I, Butz K, Hoppe-Seyler F, Groner B.

J Biol Chem. 2003 Sep 26;278(39):37610-21. Epub 2003 Jul 2.

PMID:
12842895
[PubMed - indexed for MEDLINE]
Free Article
8.

The transforming growth factor beta 1/SMAD signaling pathway involved in human chronic myeloid leukemia.

Su E, Han X, Jiang G.

Tumori. 2010 Sep-Oct;96(5):659-66. Review.

PMID:
21302608
[PubMed - indexed for MEDLINE]
9.

Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta)1: requirement for Smads, (beta)-CATENIN, AND GSK3(beta).

Clifford RL, Deacon K, Knox AJ.

J Biol Chem. 2008 Dec 19;283(51):35337-53. doi: 10.1074/jbc.M803342200. Epub 2008 Oct 23.

PMID:
18952601
[PubMed - indexed for MEDLINE]
Free Article
10.

Cooperation between TGF-beta and Wnt pathways during chondrocyte and adipocyte differentiation of human marrow stromal cells.

Zhou S, Eid K, Glowacki J.

J Bone Miner Res. 2004 Mar;19(3):463-70. Epub 2003 Dec 22.

PMID:
15040835
[PubMed - indexed for MEDLINE]
11.

Use of RNA aptamers for the modulation of cancer cell signaling.

Jeong S, Lee HK, Kim MY.

Methods Mol Biol. 2009;542:363-77. doi: 10.1007/978-1-59745-561-9_20.

PMID:
19565913
[PubMed - indexed for MEDLINE]
12.

The low-density lipoprotein receptor-related protein 10 is a negative regulator of the canonical Wnt/beta-catenin signaling pathway.

Jeong YH, Sekiya M, Hirata M, Ye M, Yamagishi A, Lee SM, Kang MJ, Hosoda A, Fukumura T, Kim DH, Saeki S.

Biochem Biophys Res Commun. 2010 Feb 19;392(4):495-9. doi: 10.1016/j.bbrc.2010.01.049. Epub 2010 Jan 20.

PMID:
20093106
[PubMed - indexed for MEDLINE]
13.

The Yin-Yang of TCF/beta-catenin signaling.

Barker N, Morin PJ, Clevers H.

Adv Cancer Res. 2000;77:1-24. Review.

PMID:
10549354
[PubMed - indexed for MEDLINE]
14.

WNT signaling pathway and stem cell signaling network.

Katoh M, Katoh M.

Clin Cancer Res. 2007 Jul 15;13(14):4042-5. Review.

PMID:
17634527
[PubMed - indexed for MEDLINE]
Free Article
15.

Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.

Qiang YW, Barlogie B, Rudikoff S, Shaughnessy JD Jr.

Bone. 2008 Apr;42(4):669-80. doi: 10.1016/j.bone.2007.12.006. Epub 2007 Dec 27.

PMID:
18294945
[PubMed - indexed for MEDLINE]
16.

Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context.

Mikels AJ, Nusse R.

PLoS Biol. 2006 Apr;4(4):e115. Epub 2006 Apr 4.

PMID:
16602827
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Insights on biology and pathology of HIF-1α/-2α, TGFβ/BMP, Wnt/β-catenin, and NF-κB pathways in osteoarthritis.

Wu L, Huang X, Li L, Huang H, Xu R, Luyten W.

Curr Pharm Des. 2012;18(22):3293-312. Review.

PMID:
22646092
[PubMed - indexed for MEDLINE]
18.

Interferon-α2b and transforming growth factor-β1 treatments on HCC cell lines: Are Wnt/β-catenin pathway and Smads signaling connected in hepatocellular carcinoma?

Ceballos MP, Parody JP, Alvarez Mde L, Ingaramo PI, Carnovale CE, Carrillo MC.

Biochem Pharmacol. 2011 Dec 1;82(11):1682-91. doi: 10.1016/j.bcp.2011.08.001. Epub 2011 Aug 6.

PMID:
21843516
[PubMed - indexed for MEDLINE]
19.

Selective inhibition of TGF-beta responsive genes by Smad-interacting peptide aptamers from FoxH1, Lef1 and CBP.

Cui Q, Lim SK, Zhao B, Hoffmann FM.

Oncogene. 2005 Jun 2;24(24):3864-74.

PMID:
15750622
[PubMed - indexed for MEDLINE]
20.

Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice.

Goumans MJ, Mummery C.

Int J Dev Biol. 2000 Apr;44(3):253-65. Review.

PMID:
10853822
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk